KRAS and neoplasm: KRAS-induced IL-6 promoted the activation of Janus activated kinase 1 (JAK1) and phosphorylation of signal transducer and activator of transcription 3 (STAT3), contributing to tumorigenic cellular processes in a variety of tumour types86–88.